Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice by sphingosine-1-phosphate 1 receptor activation

Kidney International

Volumn 80, Issue 12, 2011, Pages 1315-1327

  Park, Sang Won ^a   Kim, Minjae ^a   Kim, Mihwa ^a   D'Agati, Vivette D ^b   Lee, H Thomas ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NONE   (United States)

Author keywords

acute kidney injury; apoptosis; heat shock protein 27; inflammation; necrosis; sphingosine 1 phosphate

Indexed keywords

SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVATION; ENZYME INHIBITION; GENE OVEREXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MORPHOLOGY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RENAL PROTECTION; REPERFUSION INJURY; UPREGULATION;

EID: 82455199170     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.281     Document Type: Article

References (72)

1. Jones DR, Lee HT. Protecting the kidney during critical illness. Curr Opin Anaesthesiol 2007; 20: 106-112.
2. Borthwick E, Ferguson A. Perioperative acute kidney injury: risk factors, recognition, management, and outcomes. BMJ 2010; 341: c3365.
3. Chertow GM, Levy EM, Hammermeister KE et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998; 104: 343-348.
4. Zacharias M, Conlon NP, Herbison GP et al. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev 2008; (4): CD003590.
5. Olivera A, Kohama T, Edsall L et al. Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol 1999; 147: 545-558.
6. Cybulsky AV, Takano T, Papillon J et al. Renal expression and activity of the germinal center kinase SK2. Am J Physiol Renal Physiol 2004; 286: F16-F25.
7. Spiegel S, Milstien S. Sphingosine 1-phosphate, a key cell signaling molecule. J Biol Chem 2002; 277: 25851-25854.
8. Hofmann U, Burkard N, Vogt C et al. Protective effects of sphingosine-1- phosphate receptor agonist treatment after myocardial ischaemiareperfusion. Cardiovasc Res 2009; 83: 285-293.
9. Awad AS, Ye H, Huang L et al. Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 2006; 290: F1516-F1524.
10. Lien YH, Yong KC, Cho C et al. S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney Int 2006; 69: 1601-1608.
11. Suleiman M, Cury PM, Pestana JO et al. FTY720 prevents renal T-cell infiltration after ischemia/reperfusion injury. Transplant Proc 2005; 37: 373-374.
12. Jo SK, Bajwa A, Ye H et al. Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury. Kidney Int 2009; 75: 167-175.
13. Jin ZQ, Karliner JS, Vessey DA. Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via sphingosine kinase isoform-1 activation. Cardiovasc Res 2008; 79: 134-140.
14. Kim M, Chen SW, Park SW et al. Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury. Kidney Int 2009; 75: 809-823.
15. Kim M, Park SW, Kim M et al. Selective renal overexpression of human heat shock protein 27 reduces renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 2010; 299: F347-F358.
16. Park SW, Chen SW, Kim M et al. Selective intrarenal human A1 adenosine receptor overexpression reduces acute liver and kidney injury after hepatic ischemia reperfusion in mice. Lab Invest 2010; 90: 476-495.
17. Jablonski P, Howden BO, Rae DA et al. An experimental model for assessment of renal recovery from warm ischemia. Transplantation 1983; 35: 198-204.
18. Kim M, Kim M, Park SW et al. Isoflurane protects human kidney proximal tubule cells against necrosis via sphingosine kinase and sphingosine-1- phosphate generation. Am J Nephrol 2010; 31: 353-362.
19. Lin YF, Ko WJ, Chu TS et al. The 90-day mortality and the subsequent renal recovery in critically ill surgical patients requiring acute renal replacement therapy. Am J Surg 2009; 198: 325-332.
20. Hoke TS, Douglas IS, Klein CL et al. Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J Am Soc Nephrol 2007; 18: 155-164.
21. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int 2004; 66: 480-485.
22. Park SW, Chen SWC, Kim M et al. Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy. Lab Invest 2011; 91: 63-84.
23. Klein CL, Hoke TS, Fang WF et al. Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy. Kidney Int 2008; 74: 901-909.
24. Kelly KJ. Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 2003; 14: 1549-1558.
25. Mehta RL, Pascual MT, Gruta CG et al. Refining predictive models in critically ill patients with acute renal failure. J Am Soc Nephrol 2002; 13: 1350-1357.
26. Maceyka M, Payne SG, Milstien S et al. Sphingosine kinase, sphingosine-1- phosphate, and apoptosis. Biochim Biophys Acta 2002; 1585: 193-201.
27. Hait NC, Oskeritzian CA, Paugh SW et al. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta 2006; 1758: 2016-2026.
28. Okada T, Ding G, Sonoda H et al. Involvement of N-terminal-extended form of sphingosine kinase 2 in serum-dependent regulation of cell proliferation and apoptosis. J Biol Chem 2005; 280: 36318-36325.
29. Maceyka M, Sankala H, Hait NC et al. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J Biol Chem 2005; 280: 37118-37129.
30. Hofmann LP, Ren S, Schwalm S et al. Sphingosine kinase 1 and 2 regulate the capacity of mesangial cells to resist apoptotic stimuli in an opposing manner. Biol Chem 2008; 389: 1399-1407.
31. Liu H, Toman RE, Goparaju SK et al. Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J Biol Chem 2003; 278: 40330-40336.
32. Pitman MR, Pitson SM. Inhibitors of the sphingosine kinase pathway as potential therapeutics. Curr Cancer Drug Targets 2010; 10: 354-367.
33. Maines LW, Fitzpatrick LR, Green CL et al. Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease. Inflammopharmacology 2010; 18: 73-85.
34. Snider AJ, Kawamori T, Bradshaw SG et al. A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. FASEB J 2009; 23: 143-152.
35. Puneet P, Yap CT, Wong L et al. SphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis. Science 2010; 328: 1290-1294.
36. Allende ML, Sasaki T, Kawai H et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem 2004; 279: 52487-52492.
37. Mizugishi K, Yamashita T, Olivera A et al. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 2005; 25: 11113-11121.
38. Wadgaonkar R, Patel V, Grinkina N et al. Differential regulation of sphingosine kinases 1 and 2 in lung injury. Am J Physiol Lung Cell Mol Physiol 2009; 296: L603-L613.
39. Kim M, Kim N, Kim M et al. Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1- phosphate-dependent pathways. Am J Physiol Renal Physiol 2007; 293: F1827-F1835.
40. Zager RA, Iwata M, Burkhart KM et al. Post-ischemic acute renal failure protects proximal tubules from O2 deprivation injury, possibly by inducing uremia. Kidney Int 1994; 45: 1760-1768.
41. Lochhead KM, Zager RA. Fluorinated anesthetic exposure ''activates'' the renal cortical sphingomyelinase cascade. Kidney Int 1998; 54: 373-381.
42. Kharel Y, Lee S, Snyder AH et al. Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J Biol Chem 2005; 280: 36865-36872.
43. Olivera A, Eisner C, Kitamura Y et al. Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. J Clin Invest 2010; 120: 1429-1440.
44. Duan HF, Wang H, Yi J et al. Adenoviral gene transfer of sphingosine kinase 1 protects heart against ischemia/reperfusion-induced injury and attenuates its postischemic failure. Hum Gene Ther 2007; 18: 1119-1128.
45. Heyman SN, Brezis M, Reubinoff CA et al. Acute renal failure with selective medullary injury in the rat. J Clin Invest 1988; 82: 401-412.
46. Epstein FH, Brezis M, Silva P et al. Physiological and clinical implications of medullary hypoxia. Artif Organs 1987; 11: 463-467.
47. Lieberthal W, Nigam SK. Acute renal failure. I. Relative importance of proximal vs. distal tubular injury. Am J Physiol 1998; 275: F623-F631.
48. Ryan MJ, Johnson G, Kirk J et al. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 1994; 45: 48-57.
49. Lai LW, Yong KC, Igarashi S et al. A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia-reperfusion injury. Kidney Int 2007; 71: 1223-1231.
50. Bajwa A, Jo SK, Ye H et al. Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury. J Am Soc Nephrol 2010; 21: 955-965.
51. Bruey JM, Ducasse C, Bonniaud P et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2000; 2: 645-652.
52. Arrigo AP, Firdaus WJ, Mellier G et al. Cytotoxic effects induced by oxidative stress in cultured mammalian cells and protection provided by Hsp27 expression. Methods 2005; 35: 126-138.
53. Kusner DJ, Thompson CR, Melrose NA et al. The localization and activity of sphingosine kinase 1 are coordinately regulated with actin cytoskeletal dynamics in macrophages. J Biol Chem 2007; 282: 23147-23162.
54. Kozawa O, Niwa M, Matsuno H et al. Sphingosine 1-phosphate induces heat shock protein 27 via p38 mitogen-activated protein kinase activation in osteoblasts. J Bone Miner Res 1999; 14: 1761-1767.
55. Takai S, Tokuda H, Matsushima-Nishiwaki R et al. Phosphatidylinositol 3-kinase/Akt plays a role in sphingosine 1-phosphate-stimulated HSP27 induction in osteoblasts. J Cell Biochem 2006; 98: 1249-1256.
56. Natsume H, Adachi S, Takai S et al. (-)-Epigallocatechin gallate attenuates the induction of HSP27 stimulated by sphingosine 1-phosphate via suppression of phosphatidylinositol 3-kinase/Akt pathway in osteoblasts. Int J Mol Med 2009; 24: 197-203.
57. Lee HT, Jan M, Bae SC et al. A1 adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo. Am J Physiol Renal Physiol 2006; 290: F1367-F1375.
58. Lee HT, Kim M, Jan M et al. Renal tubule necrosis and apoptosis modulation by A1 adenosine receptor expression. Kidney Int 2007; 71: 1249-1261.
59. Khan TN, Sinniah R. Study of renal tubular glycoconjugates in tubulointerstitial damage using conjugated lectins. J Pathol 1993; 170: 187-196.
60. Truong LD, Phung VT, Yoshikawa Y et al. Glycoconjugates in normal human kidney. A histochemical study using 13 biotinylated lectins. Histochemistry 1988; 90: 51-60.
61. Lee HT, Kim M, Kim J et al. TGF-beta1 release by volatile anesthetics mediates protection against renal proximal tubule cell necrosis. Am J Nephrol 2007; 27: 416-424.
62. Vessey DA, Kelley M, Karliner JS. A rapid radioassay for sphingosine kinase. Anal Biochem 2005; 337: 136-142.
63. Liu H, Sugiura M, Nava VE et al. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem 2000; 275: 19513-19520.
64. Song JH, Kim M, Park SW et al. Isoflurane via TGF-beta1 release increases caveolae formation and organizes sphingosine kinase signaling in renal proximal tubules. Am J Physiol Renal Physiol 2010; 298: F1041-F1050.
65. Lee HT, Kim M, Kim M et al. Isoflurane protects against renal ischemia and reperfusion injury and modulates leukocyte infiltration in mice. Am J Physiol Renal Physiol 2007; 293: F713-F722.
66. French KJ, Schrecengost RS, Lee BD et al. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 2003; 63: 5962-5969.
67. French KJ, Upson JJ, Keller SN et al. Antitumor activity of sphingosine kinase inhibitors. J Pharmacol Exp Ther 2006; 318: 596-603.
68. Wong L, Tan SS, Lam Y et al. Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases. J Med Chem 2009; 52: 3618-3626.
69. Sanna MG, Wang SK, Gonzalez-Cabrera PJ et al. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat Chem Biol 2006; 2: 434-441.
70. Lee HT, Gallos G, Nasr SH et al. A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2004; 15: 102-111.
71. Lee HT, Xu H, Nasr SH et al. A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion. Am J Physiol Renal Physiol 2004; 286: F298-F306.
72. Joo JD, Kim M, D'Agati VD et al. Ischemic preconditioning provides both acute and delayed protection against renal ischemia and reperfusion injury in mice. J Am Soc Nephrol 2006; 17: 3115-3123.